Literature DB >> 22197672

Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.

Hitomi Yuki1, Teruki Honma, Masayuki Hata, Tyuji Hoshino.   

Abstract

In drug discovery process, improvement of ADME/Tox properties of lead compounds including metabolic stability is critically important. Cytochrome P450 (CYP) is one of the major metabolizing enzymes and the prediction of sites of metabolism (SOM) on the given lead compounds is key information to modify the compounds to be more stable against metabolism. There are two factors essentially important in SOM prediction. First is accessibility of each substrate atom to the oxygenated Fe atom of heme in a CYP protein, and the other is the oxidative reactivity of each substrate atom. To predict accessibility of substrate atoms to the heme iron, conventional protein-rigid docking simulations have been applied. However, the docking simulations without consideration of protein flexibility often lead to incorrect answers in the case of very flexible proteins such as CYP3A4. In this study, we demonstrated an approach utilizing molecular dynamics (MD) simulation for SOM prediction in which multiple MD runs were executed using different initial structures. We applied this strategy to CYP3A4 and carbamazepine (CBZ) complex. Through 10 ns MD simulations started from five different CYP3A4-CBZ complex models, our approach correctly predicted SOM observed in experiments. The experimentally known epoxidized sites of CBZ by CYP3A4 were successfully predicted as the most accessible sites to the heme iron that was judged from a numerical analysis of calculated ΔG(binding) and the frequency of appearance. In contrast, the predictions using protein-rigid docking methods hardly provided the correct SOM due to protein flexibility or inaccuracy of the scoring functions. Our strategy using MD simulation with multiple initial structures will be one of the reliable methods for SOM prediction.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197672     DOI: 10.1016/j.bmc.2011.12.004

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.

Authors:  Ilia G Denisov; Yelena V Grinkova; Javier L Baylon; Emad Tajkhorshid; Stephen G Sligar
Journal:  Biochemistry       Date:  2015-03-25       Impact factor: 3.162

2.  Biochemical analysis of a multifunctional cytochrome P450 (CYP51) enzyme required for synthesis of antimicrobial triterpenes in plants.

Authors:  Katrin Geisler; Richard K Hughes; Frank Sainsbury; George P Lomonossoff; Martin Rejzek; Shirley Fairhurst; Carl-Erik Olsen; Mohammed Saddik Motawia; Rachel E Melton; Andrew M Hemmings; Søren Bak; Anne Osbourn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

3.  Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes.

Authors:  Loai Basheer; Keren Schultz; Merav Fichman; Zohar Kerem
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

4.  Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models.

Authors:  Loai Basheer; Keren Schultz; Zohar Kerem
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

5.  The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients.

Authors:  Chahra Chbili; Anis Hassine; Aicha Laouani; Sana Ben Amor; Manel Nouira; Sofiène Ben Ammou; Saad Saguem
Journal:  Arch Med Sci       Date:  2016-05-20       Impact factor: 3.318

6.  Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors.

Authors:  Yusra Sajid Kiani; Kara E Ranaghan; Ishrat Jabeen; Adrian J Mulholland
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

7.  Identification of key amino acid residues toward improving the catalytic activity and substrate specificity of plant-derived cytochrome P450 monooxygenases CYP716A subfamily enzyme for triterpenoid production in Saccharomyces cerevisiae.

Authors:  Jutapat Romsuk; Shuhei Yasumoto; Hikaru Seki; Ery Odette Fukushima; Toshiya Muranaka
Journal:  Front Bioeng Biotechnol       Date:  2022-08-19

8.  A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes.

Authors:  Richard Lonsdale; Sarah L Rouse; Mark S P Sansom; Adrian J Mulholland
Journal:  PLoS Comput Biol       Date:  2014-07-17       Impact factor: 4.779

9.  Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).

Authors:  Deepak K Lokwani; Aniket P Sarkate; Kshipra S Karnik; Anna Pratima G Nikalje; Julio A Seijas
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.